NCT05136040

Brief Summary

The primary aim of this study was to compare the effects of two different low-dose bupivacaine used in spinal anesthesia on intraoperative hemodynamics in cesarean section operations.Investigators think that low-dose bupivacaine and fentanyl mixture applied in cesarean section cause fewer hemodynamic changes,provide adequate anesthesia and analgesia quality,cause fewer side effects,and postoperatively,patients may return to their daily activities more quickly.This study was conducted on 80 pregnant women undergo an elective cesarean section.Patients were randomly allocated in GrupA and GroupB. Combined spinal-epidural anesthesia was performed in the sitting position using the needle-inside-needle technique.After cerebrospinal fluid flow was observed, GroupA patients were given a solution containing 5 mg isobaric bupivacaine+15 µg fentanyl (1.3 ml),and Group B was administered a solution containing 7 mg isobaric bupivacaine+15 µg fentanyl (1.7ml).Hypotension,bradycardia,duration of analgesia,postoperative nausea and vomiting were recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2019

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

October 21, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 26, 2021

Completed
Last Updated

December 8, 2021

Status Verified

November 1, 2021

Enrollment Period

8 months

First QC Date

October 21, 2021

Last Update Submit

November 25, 2021

Conditions

Keywords

Ceseaean sectionSpinal anesthesiaHemodynamics

Outcome Measures

Primary Outcomes (1)

  • The primary aim of study was to compare the effects of two different low-dose bupivacaine used in spinal anesthesia on intraoperative systolic and diastolic blood pressure (mmHg) in cesarean section operations.

    Intraoperatif hemodynamics

    during cesarean procedure

Study Arms (2)

Group İzobarik bupivakain (5 mg) + fentanil

ACTIVE COMPARATOR

Patients were given a solution containing 5 mg isobaric bupivacaine + 15 µg fentanyl (1.3 ml)

Drug: Bupivacaine

Group İzobarik bupivakain (7 mg) + fentanil

ACTIVE COMPARATOR

Patients were givena solution containing 7 mg isobaric bupivacaine + 15 µg fentanyl (1.7 ml)

Drug: Bupivacaine

Interventions

Two Different Low-Doses Of Isobaric Bupivacaine ( Group İzobarik bupivakain (5 mg) + fentanil and Group İzobarik bupivakain (7 mg)+ fentanyl ) were administered to the subarachnoid space

Group İzobarik bupivakain (5 mg) + fentanilGroup İzobarik bupivakain (7 mg) + fentanil

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • ASA I-II
  • Pregnant women
  • years of age
  • BMI\<40kg/m2
  • cm in height

You may not qualify if:

  • Patients with hypertension induced by emergency obstetric surgery
  • Significant systemic disease,
  • Multiple pregnancies,
  • Fetal or placental abnormality,
  • Hypersensitivity or allergy history to the drugs to be used in the study
  • Contraindicated neuraxial anesthesia,
  • Infection at or around the region to be anesthetized,
  • Coagulation abnormalities
  • Patients unable to decide or unwilling to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aysenur Dostbil

Yakutiye, Erzurum, 25000, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Bupivacaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Mehmet Aksoy, MD

    Ataturk University, Department of Anesthesiology and Reanimation

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 21, 2021

First Posted

November 26, 2021

Study Start

October 15, 2018

Primary Completion

June 15, 2019

Study Completion

June 15, 2019

Last Updated

December 8, 2021

Record last verified: 2021-11

Locations